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TheMHC is bounded by the telomeric class I HLA genes and the centromeric
class II HLA genes . Thecentral genesinclude theC4, C2, Bf, 21 hydroxylase (Cyp21),
TNF, BAT, and other genes . Most, if not all, of these genes are duplicated and poly-
morphic. In the case ofC4 and Cyp 21, it is known that the gene copynumber can
vary from one to three per haplotype (1-3) .
We have used the term "ancestral haplotype" (AH) t to describe conserved haplo-
types that appear to be identical between subjects not known to be related (4-6) .
TheseAHs have a specific content of alleles at all MHC loci and have a particular
genomic length as determined by pulsed field gel electrophoresis (PFGE) (6) . In local
caucasoids, some 30 AHs, and recombinants betweenthese, account foralmost 90%
of the haplotypes found after family studies. These 30 AHs account for almost all
of the known linkage disequilibria and almost all but the lowest frequency alleles
so far identified (4) . It has already been shown that certain AHs have a particular
gene copy number at the C4 and Cyp21 loci (3).
The quantitation of gene copy number can be rather difficult . The simpler ap-
proaches, such as counting the number of fragments afterRFLP analysis (7), are
subject to degrees of uncertainty so that progress has been relatively slow. Densito-
metric comparison ofthe intensity of hybridizingfragments can be helpful in deter-
mining gene copy number. However, this approach is only really useful when frag-
ments are compared within onelane so as to eliminate differences due to variations
in DNA concentration and degree of restriction enzyme digestion.
PFGE allows the analysis of fragments ofmore than onemegabase, and in hetero-
zygous subjects, the physical separation of AHs of different lengths (4, 6) . In this
study we show that densitometric comparison of different AHs after PFGE separa-
This work was supported by the National Health and Medical Research Council, Western Australian
Arthritis and Rheumatism Foundation and the Immunogenetics Research Foundation .
This is publication No . 8908 ofthe Departments ofClinical Immunology, Royal Perth Hospital, Queen
Elizabeth II Medical Centre and the University of Western Australia .
Address correspondence to Dr. R . L . Dawkins, Department of Clinical Immunology, Royal Perth
Hospital, GPO Box X2213, Perth, Western Australia 6001 .
1 Abbreviations used in this paper: AH, ancestral haplotype.
J. Exp . MED . ® The Rockefeller University Press - 0022-1007/90/06/2101/14 $2.00
￿
2101
Volume 171 June 1990 2101-21142102
￿
DIFFERENCES IN GENE COPY NUMBER BETWEEN HAPLOTYPES
tion gives the expected results when the gene copy number is already known. Ac-
cordingly, we have used this approach to estimate the gene copy number in other





EBVtransformed cell lines were obtained from fully genotyped individuals
with selected AHs (Table I). For the present study, heterozygous cell lines were of particular
value. Disease associations with these AHs have been reported previously (8-11).
DNA Preparation, Restriction Enzyme Digestion, and PFGE.
￿
The methods have been described
previously (6, 12, 13). Briefly, genomic DNA was prepared from EBVtransformed cells and
embedded in low melting temperature agarose plugs. DNA plugs containing 6 x 105 cells
were treated with Proteinase K, washed in Tris-EDTA buffer (pH 7.5), equilibrated with the
appropriate restriction buffer and digested with restriction enzymes as described (6, 12). Elec-
trophoresis was performed as described (6) .
Southern Hybridization.
￿
After PFGE, the gels were stained in ethidium bromide and ap-
propriate measurements were recorded for the lambda and yeast markers. The gels were then
treated with HCl and NaOH, to depurinate and denature the DNA, followed by transfer
to nylon membranes by alkaline transfer (14). The membranes were hybridized with probes
labeled by the random priming method (15), washed, and exposed to x-ray film according
to standard methods. Probes were stripped off the membranes by treatment with NaOH.
Stripping was carefully monitored by overnight exposure to x-ray films and the membranes
were then used for reprobing (6).
Human cDNA probes were used to quantitate gene copy numbers. The probes for Bf(16),
C4 (17), and DRB (18) were provided for study in the 10th International Histocompatibility
Workshop (19). All have been fully characterized (2, 20-23). The 1.6- + 0.66-kb Cla I +
Barn HI probe for Bf appears to be specific for this gene. The 0.5-kb Bam HI + Kpn I C4
probe (pATA) hybridizes with the Tends of C4A and B. The 0.786-kb Hind III + Sal I
DRB probe including most of the coding sequence may cross-hybridize with other class II
genes under low stringency conditions. The 2 .1-kb Barn HI probe for Cyp21 (pC21/3c) was
kindly provided by Dr. P. White (24) and has been shown to react with Cyp21A and B (2,
3, 21, 25). The 0.8-kb Eco RI TNFa probe, which contains the entire coding region of ma-
ture TNF, was kindly provided by Dr. H. M. Shepard (26; Genentech Inc., South San Fran-
cisco, CA) and has been fully characterized (27, 28). There is no detectable hybridization
ofthis probe with TNF beta contained within genomic clones of 8.1 or 57 .1 (Du et al., manu-
script in preparation).
Evaluation of Gene Copy Number by Densitometry.
￿
Quantitative determination of gene copy
number by densitometry was carried out with a video densitometer (Bio-Rad Laboratories,
Richmond, CA; Model 620, settings: filter frequency, 4.0 lines/mm; enhancement, 0 .1/mm;
boost factor, 1). Integrated areas under the curve corresponding to specific DNA bands were
used for the calculation of optical density (OD) ratios. The comparative estimation of gene
copy numbers carried by different haplotypes was only performed when two distinct haplotype-
specific DNA fragments were obtained from a single heterozygous individual and it was pos-
sible to compare these two haplotypes by signal differences as determined by densitometry
(Fig. 1). The haplotype-specific DNA fragments were defined by PFGE analysis of a number
of homozygous cell lines (6). It should be emphasized that the present approach depends
upon the physical separation of each haplotype, complete stripping before reprobing, and
quantitative densitometry.
Results
In the first instance we selected subjects known to be heterozygous for the AHs




Ancestral Haplotypes Used in This Study
Gene copy numbers were assigned to each AH at C4, Cyp21, and DRB loci
by using the observed O.D. ratios and the data provided in Fig. 5.
?, Not defined; `, provisional assignment.
was used in the PFGE studies. After Southern transfer, the blots were probed se-
quentially paying careful attention to stripping after each hybridization.
As shown in Fig. 1, AHs could be separated and their densities compared. It was
immediately obvious that the ratios between the shorter and longer haplotypes de-
pended upon the probe used.
Densitometric scanning allowed objective determination of densitometric ratios.
For example, it wasclearthat thereareapproximately twice as many C4 and Cyp21
genes on the 57.1 AH as compared with the 8.1 AH.
To confirm that thesedensitometricratios segregated with haplotypes, family studies
were undertaken. As shown in Figs. 2 and 3, consistent results were obtained,
confirming that it was possible to separate AHs and to use objective densitometry.
At the same time we were able to compare ratios in siblings so that an estimate of
scatter was possible.
Since there areseveralvariablesdeterminingthedensityoffragmentsafterSouthern
blotting and hybridization, we were concerned about thereproducibility oftheassay.
The effective exposure time was studied by probing with C4 after digestion with
Mlu I or Not I. For each fragment the absolute OD area increased between 1 and
8 d as expected. Importantly, the ratio between fragments remained constant over
this period.
Reproducibility was examined by comparing samples within and between runs.
Afterdigestion with Not I andprobingforC4, three differentheterozygous cell lines
gave ratios of -0.6, 1.0, and 1.4 (see Fig. 4, second panel). When the three cell lines
were triplicated on the same run or repeated on three separate occasions, ranges
of 0.4-0.6 (mean t SD = 0.53 t 0.07), 0.9-1.2 (mean t SD = 1.04 t 0.08), and
1.3-1.6 (mean t SD = 1.43 t 0.12), respectively, were obtained; there wasno overlap
even when tested on completely different runs.
Having demonstrated the potential value of our approach we examined several





7 .1 7 3 7 7 S 3 1 2 6 2 2 3
8.1 10 1 7 8 S QO 1 3 2 1 1 3
18.2 1 33 5 18 F1 3 QO 3 2 1 1 3
44.1 1 2 5 44 S 3 QO 4 7 3-4 2 4
44.2 1 29 4 44 F 3 1 7 2 2 2 4
57 .1 3 1 6 57 S 6 1 7 9 2 2 3-4
60.3 1 2 3 60 S QO 2 13 ? 3-4 3 3-4
62.1 5 2 3 62 S 3 3 4 8 2 2 4
62 .2 4 ? 3 62 S 4 2 4 3 ? ? 4
65.1 1 ? 8 65 S 2 1 + 2 1 5 3 3 2
27 .1 1 ? 2 27 S 3 1 4 ? 2 2 42104
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FIGURE 1 .
￿
SingleC4 and Cyp21 genes on the 8.1 ancestral haplotype demonstrated by densi-
tometryonPFGE separated DNA fragments. The genotype ofthe cell line is HLAAl, B8, BfS,
C4AQO, C4Bl, DR3, DQw2 (8 .1); A32, B57, BfS, C4A6, C4B1, DR7, DQw9 (57 .1) . After di-
gestion with Not I the twoAHswere separatedbyPFGE . After Southern transfer, themembrane
was hybridized sequentially with each of the three probes . Since it is known that the 8.1 and
57 .1 AHs are carriedby the 940- and 1,110-kb fragments, respectively (6), it was possible to com-
pare the densities ofthe two haplotype-specific fragments . As shown quantitative scanning gave
ratios of 1.1 for Bf and 0.6 forC4 and Cyp21A+B respectively . All AHs including 8.1 and 57 .1
carry only one copy of Bf so that a heterozygous subject would be expected to give an optical
density ratio of 1 . Numerous previous studies have shown that the 8.1 AH carries only one copy
of C4 because of a deletion resulting in C4AQ0 . The observed OD ratio of 0.6 is close to the
expected of 0.5 . Similarly the 8.1 AH lacks 21A and again the observedOD ratio is close to that
expected . It should be emphasized that the present approach dependsupon the physical separa-
tion ofeachhaplotype, complete stripping before reprobingand quantitative objective densitom-
etry .ZHANG ET AL.
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FIGURE 2 . Haplotype-specific frag-
ments segregate within families and
can be used to quantitate gene copy
number . It canbeseen that afterNllu I
digestion the father (ab) is homozy-
gous for fragments of 180 kb, whereas
themother (cd) is homozygous forfrag-
ments of 230kb. Comparison ofopti-
cal densities in the children revealed ra-
tios close to the expected 1.0 for BE
Since both of the 180-kb fragments
carry the BfS, C4AQ0, C4B1 complo-
type derived from the 8.1 AH, d car-
ries BfS, C4A3, C4B1 . With the C4
probe the a/d andb/c ratios were 0.4
and0.3-0 .4 respectively . It is concluded
that haplotypes cand d contain either
two or three copies of C4 . Similar re-
sults were obtained after reprobing
with Cyp21A+B . Thus the ratios for
a/d and b/c were 0.5 and 0.4-0.6, re-
spectively, suggesting that both the c
and d haplotypes contain two copies of
Cyp21A or B . IfequalnumbersofC4
and 21 hydroxylaseare assumed, itap-
pears that haplotypes aandb have one
of each and c and dhave twoofeach.
It is likely that the expected ratios of
0.5may actually yield ratiosof0.3-0 .6 .
heterozygotes carrying AHs with known gene copy numbers (Fig . 4). As shown in
Fig . 5, similar ratios were obtained when haplotypes with equal gene copy numbers
were compared, irrespective of whether there were one or two genes on each haplo-
type . No overlap was observed when haplotypes with 1 :2 or 2:4 genes were com-
pared with those with 1 :1 or 2:2 genes . On the other hand, we have not established
that the technique would be able to measure reproducible differences between 2 :3
or 3 :4 genes .
From the results shown in Figs . 4 and 5, it is often possible to define the likely
gene copy number given a particular OD ratio. The ranges so obtained were essen-
tially the same as those expected from thecomparison of siblings (see Figs . 2 and 3) .
Having demonstrated that the approach provides predictable results when gene2106
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FIGURE 3 .
￿
Family segregation analysis demon-
strates correct estimation of gene copy number
by densitometric comparison . A situation simi-
larto that described in Fig. 2was observed in fam-
ily REE. With Bf probing afterMlu I digestion
haplotypes a, b, and cshowed similar density in
three children as indicated by ratios close to 1.0
(top) . With C4 (middle) and Cyp21A+B (bottom)
probes theOD ratios for b/cand a/cwere 0 .3 and
0.4 . Since haplotypes a and b contain the BfS,
C4AQ0, C4B1 complotype derived from the 8.1
AH, it is estimated that these haplotypes carry
one copy ofC4 and 21 hydroxylase genes, whereas
haplotype c carries two copies of each.
copy number is known, we then studied otherAHs (Table I) in heterozygous indi-
viduals . Analysis of heterozygotes containing one characterized and one uncharac-
terizedAH enabledus to estimate gene copy numbers at C4, Cyp21, andDRB loci .
As shownin Table 1, there aredifferences in thenumbersofgenes carriedby different
AHs. The number is always the same for thoseAHs where multiple examples have
been tested . In the case of DRB, the probe may cross-hybridize with other class
II genes under certain conditions, but it appears that the number of genes may re-
late toDR specificity determined by serology. There may be exceptions as in the
case of 57 .1, but further studies are required .
The blots used to estimate gene copy number for C4, Cyp21, and DRB were re-
stripped and reprobed forTNFot . Once again, haplotype-specific differences were
obtained (Fig . 6) . Depending upon the ancestral haplotypes, the ratios varied over
the range found for C4, Cyp21, and DRB; the shorter 57.1 gave more than twice
the density of the longer 8.1 AH . By contrast, the shorter 7 .1 yielded only half the
signal of the longer 62.1 . Using cell line THE carrying 57 .1 and 8.1, it was possibleFIGURE 4 .
￿
Quantitative determination of gene copy numbers carried by different AHs after
physical separation ofgenomic DNA by PFGE. PFGE Southern blots of samples digested with
Not I were probed with Bf, C4, Cyp21A+B, and DRBprobes ensuring complete stripping after
each hybridization. The gene copy numbers carried by each fragment or haplotype were esti-
mated from the OD ratio ranges as shown in Fig . 5 . It is important to note that with the Bf
probe all the three cells showed ratios of -1.0 (also seen in Figs. 2 and 3) . However, various ra-
tios were seen after probing for C4, Cyp21, andDRB and therefore different numbers of genes
were assigned to different haplotypes as shown . Four DRB genes were assigned to 62 .1 based
on references 43 and 44 . Accordingly, the 7.1 may have 3 DRB genes (X), while the 8.1 and
57 .1 AHs may carry Y and Z genes, respectively (Y and Z represent 3-4 genes).
Observed

















is reflected by OD ratios with
ranges derived from individu-
alswith known gene copy num-
ber. Anumber ofheterozygous
cell lines with two distinct
haplotype-specific DNA frag-
ments ("short" and "long") have
been physically separated by
PFGE . Densitometriccompar-
ison showed that the observed
OD ratios fit those predicted
from fully genotyped individu-
als with knowngene copy num-
bers forBf(1 :1, mean t 2 SD
= 1 .0 t 0.22), C4 andCyp21
(1 :2, mean t 2 SD = 0.43 t
0.20;2:2, mean t 2SD = 0.96
t 0.26; and 3:2), and DRB
(2:4) .2108
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ration ofAHs, probing forTNF
reveals differences in densito-
metric ratios . Six heterozygous
cell lines were subjected to
PFGE after Not I digestion . As
shown in Fig . 6, twoDNA frag-
ments could be demonstrated
after probing for TNF . AHs
57 .1, 18 .2, 65 .1, and 7 .1 are car-
ried by shorter fragments
(-290 kb), while AHs 8 .1 and
62 .1 are represented by longer
fragments (-1,200 kb) . As
shown,OD ratios are similarfor
the cell lines TRE, MAD, and
OSU with the same two AHs .
Different OD ratios were ob-
tined with the cell lines HIB ,
FAU and ATK. Results were
similar when a cell line was re-









and between runs (different ____AH
8.1 8.1 8.t 8.1 62 .1 62 .1 symbols) .
Family TRE MAD OSU HIB FAU ATK
FIGURE 6 .
￿
Differences in fragment intensities with a probe for
TNF after physical separation of ancestral haplotypes by PFGE .
Three heterozygous cell lines were digested with Not I and the
component AHs were separated by PFGE . The sizes of the Not
I/TNF fragments are asdescribedpreviously (6) . As shown, there
were major differences in fragment intensities when twoAHs were
compared and therefore different densitometric ratios were ob-
tained . On the left, it can be seen that 8 .1 and 57 .1 differ by a fac-
tor of -2 . A reciprocal difference is seen when 62 .1 is compared
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to compare results within and between runs (Fig. 7). Results were similar on all
occasions. Three unrelated subjectswith the same AHs were compared; the results
in all three were very similar, especially within the same run. When a cell with 8.1
and 18.2 was tested on two separate runs, ratios of-1.0 were obtained, suggesting
that there is at least a twofold difference between 18.2 and 57.1.
Discussion
Until recently, the MHC has been seen as a cluster of HLA genes principally
concerned with presentation and other antigen-specific phenomena. Other genes
within the complex have been regarded as accidental or irrelevant (29, 30).
Following the pioneering work ofAlper et al. (31) and Dupont et al. (32), it be-
came quite clear that alleles at the C2, Bf, C4, and Cyp21 loci are associated with
particular alleles at the HLA class I and classII clusters andthat someHLA-associated
diseases are actually due to abnormalities ofthe central genes (e.g., C2 deficiency,
C4 deficiency, and 21 hydroxylase deficiency). During the same period our studies
ofautoimmune diseases had revealed that certain diseases were associatedwith par-
ticular supratypes (or combinations of alleles at various MHC loci). This led us to
suggest that the association might reflect quantitative changes in the expression of
MHC genes other than the HLA genes known at the time (8, 33). Subsequently,
we beganto characterize supratypes associated with disease and showed, in a variety
ofsituations, that it wasthe supratype rather than any particular allele whichprovided
the best marker ofdisease susceptibility (9-11, 34, 35).
By studying the genomic structure of particular supratypes, it became obvious
that we were actually identifying ancestral haplotypes viz. highly conserved struc-
tures with a particular content ofalleles, deletions, and duplications throughout the
MHC (3, 4, 6).
Theseconclusionswere confirmed inmany respects throughcollaborative studies
undertaken during the 10th International Histocompatibility Workshop.
Followingfamily studies oflocal Caucasoidswe haveidentified 30AHs that (with
recombinants between 2 or 3 of these) account for almost all alleles at all MHC
loci and that explain the observed linkage disequilibria between alleles at two or
more loci. Thus, the MHC can be seen in the context ofa rather limited number
ofAHs that have remained essentially unique throughout human evolution. Each
has a particular length and a particular content ofalleles, deletions, and duplica-
tions. Elsewhere we have argued that many ofthese AHs can be identified, in large
measure, in nonhumanprimates, althoughsome appear to beofmore recent origin
(36). ThoseAHsthatcontainlargedeletionsareassociated withautoimmunediseases.
These concepts suggest that the MHC has been conserved en bloc and that cen-
tral non-HLA genes may be ofcritical importance. As but one example, it is now
known thatC2, Bf, C4, andTNFare all potentialregulators ofBcell differentiation
andfunction, andwefavorthe hypothesis that aparticular cascade ofdifferent poly-
morphic forms ofthese gene products may have greater or lesser consequences on
global antibody production. Thus, the central part ofthe MHC may be important
in terms of antibody-mediated defense and autoantibody-mediated autoimmune
disease.
To test some ofthese hypotheses we require methods for quantitating gene copy2110
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numbers within the MHC . Ideally the method should be appropriate for all genes,
and perhaps even for those that have not been characterized fully at present.
In approachingthisaimwe were favorably influenced by our experience in quan-
titating the protein products of the C4 genes . This approach, pioneered by Chris-
tiansen et al . (37), has been extended following the introduction of improved tech-
niques in protein allotyping (38, 39) and now allows the accurate detection of from
0 to 3 functional C4 genes per haplotype (40, 41) .
The present report describes our experience with objective densitometric assess-
ment of gene copy number after PFGE and Southern blotting . We have taken ad-
vantage of the fact that PFGE allows physical separation ofmany AHs so that two
AHs can be compared within the one lane. Further, by taking account of the fact
that the gene copy number of C4, Cyp21, andDRB can be deduced for some AHS
(1-3, 42-44) we have been able to evaluate the system anddevelop appropriatetech-
niques for the quantitation of other MHC genes .
Gene copy number is a function of the particular AH, at least in the case of C4
and Cyp21 . The same appears to be true of DRB, although further studies using
locus-specific probes are required . To date we have shown that the DRB-SIV sub-
probe (44) gives similar results to those presented above (Zhang et al ., manuscript
in preparation) . AHs with the same serological specificity have the same or similar
numbers ofDRB genes . Thus, immunological reactions apparently reflecting the
DRB serological specificities could actually relate to the gene copy number as well
as the protein sequence .
It should be emphasized that theapproach described does notdistinguish between
functional genes and pseudogenes. For example, in the case of Cyp21, most AHs
contain one pseudogene (21A) and one functional gene (21B) but we include both .
Similarly in the case ofDRB, pseudogenes will be included (44) . By contrast most,
if not all, C4 genes are functional .
With respect to TNF, our results reveal at least twofold differences betweenAHs.
While variations in gene copy number may be responsible, interpretation is more
complicated than in the case of C4, Cyp21, and DRB. The TNF probe should be
specific forTNFa under the present conditions but it is not yet known how much
different AHs vary with respect to TNF sequence and organization . Recently we
have shown that the sameTNFa probecandistinguish between AHs with or without
a Nco I site within TNF0 (27) and there may be farmore sequence polymorphism
oftheTNF gene family than previously appreciated (Duet al ., manuscript in prep-
aration) . Furthermore, someAHs contain hybrid C4 andDRB genes and it is pos-
sible that a similar phenomenon occurs elsewhere within the MHC, possibly in-
cluding hybrids between different TNF genes . These possibilities are under
investigation at present .
Since Not I separation results in fragments of very different length, quantitation
ofTNF will be less precise than in the case of C4, Cyp21, andDRB. However, since
theOD ratios varied from -0.5-2.5 (see Fig. 7), and since the differenceswere haplo-
type specific, we conclude that there can be important qualitative and/or quantita-
tive differences between at least some haplotypes . It may be relevant that TNF ap-
pears to be an important mediator involved in the regulation ofB cell function (45,
46) and differences in regulation or gene copy number could influence the amount
of product produced . A recent study has shown that production ofTNF is relatedZHANG ET AL.
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to H-2 haplotypes in the mouse (47), and a similar possibility has been suggested
in man; individuals with HLA DR2 have low production of TNF by monocytes
activated with LPS (48-50). Moreover, HLADR3 subjectsmayalsobelowresponders
when compared with subjects with HLA DR7, DR4, and DRl (48, 49). These ob-
servations may relate to the present results since HLA DR2 and DR3 are carried
by AHs 7.1, 8.1, and 18.2, respectively, and these three AHs have less TNF signal
than 57.1 and 62.1 carrying HLA DR7 and DR4, respectively.
The 8.1 AHisparticularlyinterestingbecause itcontains a C4 null (8, 33), apoly-
morphism ofTNF at the RFLP level (27), and as shown here, reduced gene copy
numbers ofC4, Cyp21, DRB, and possibly TNF. Any or all ofthese characteristics
could be relevantto its association with autoimmune diseases such as SLE. Recently,
Jacob andMcDevitt (1988) haveshown that TNFdelays the developmentofalupus-
like disease in a murine model (51). Others have extended these observations (52).
We therefore propose that predisposition to autoimmune diseases may be related
to relative deficiencies of the products of central MHC genes.
Summary
Wehave examined thehypothesis that MHC ancestralhaplotypes have aspecific
content ofgenes regulatingthe extent ofautoimmunereactions. Gene copy number
was quantitated by objective densitometry after PFGE was used to separate hetero-
zygous AHsofdifferent lengths. Initiallywe analyzed examples ofknown gene copy
number at the C4 and 21 hydroxylase loci and showed that the approach provides
predictable results.
We then studied heterozygotes containing one characterized and one uncharac-
terized AH with particular attention to the gene copy number at the C4, Cyp2l,
and DRBloci. Each AH studiedhas a characteristicgene copy numberateach locus
studied. The same maybe true ofTNF, but otherpossibilities must be considered.
AHs are markers forextensive chromosomal segments including particular numbers
ofseveral functional genes. Since AHs mark susceptibility to autoimmune disease,
differences in gene copy number may be implicated.
Wearegrateful toK. TokunagaandtoH. Tabarias, R. Darovic, M. Griffiths, andB. Brestovac
fortechnical assistanceand to T Gould and M. MacDougallfor preparing the manuscript.
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